Dr. Anne Marie Morse explains the bidirectional relationship between depression and sleep health, and how it impacts HCPs. Kirk Huntsman, Chairman & CEO of Vivos Therapeutics, on advancing care in the sleep medicine space. Dr. Anne Marie Morse discusses the troubling connection between sleep disorders and dementia. Transient ischemic attack (TIA) is associated with long-term cognitive decline. The 15-year absolute risk for completed suicide among individuals with headache was 0.21%. The caps on the end of chromosomes are called telomeres. A recent study sought to better understand the clinical presentation, and prognosis of IgG4-related pachymeningitis. The FDA approved esketamine nasal spray for the treatment of adults living with major depressive disorder. Researchers developed an artificial intelligence algorithm that may improve the diagnosis of REM sleep behavior disorder. A new model called the Florey Dementia Index (FDI) can accurately predict the age at onset of MCI and AD. Dr. Anne Morse provides a run-down of the important trends, and therapeutic innovations to occur in sleep medicine this year. Dr. Anne Marie Morse provides some gentle reminders for the health implications of over-indulgence during the holidays. Dr. Morse defines this "new sleep entity" and how parents can manage it amid the holidays. Intact human brain tissue was used by the researchers. The research group will design a vaccine that won't promote inflammation. Researchers are making significant advancements in spinal neuromodulation for neuromuscular disorders and injuries. This study expands the understanding of the biologic mechanism behind monogenic autism. Dr. Anne Marie Morse talks about parasomnias, and how they affect quality of life in people who have them. Strict neurologic criteria were applied to the researcher's search strategy. The genetic and environmental implications of air pollutants prompt thoughtful consideration for adapting urban design.